Abstract
The present study was undertaken to establish the developmental pattern of urinary endothelin-1 (ET-1) excretion and to define its possible role in mediating pathophysiological changes related to perinatal asphyxia/infection and dopamine treatment. Urinary ET-1 levels were measured by radioimmunoassay in 7 full-term neonates (mean gestational age 39.3 weeks) on days 1, 3 and 5, and in 9 pre-term neonates (mean gestational age 30.8 weeks) on days 1, 3, 5, 7 and weekly thereafter for 5 consecutive, weeks. The results were compared with those of three age-groups of 30 normal children (4–8 years, 9–12 years and 13–18 years); each group, consisted of 10 children. The influence of severe cardiopulmonary distress (n=16, mean gestational age 33.9 weeks, post-natal age 3.3 days) and dopamine administration in a dose of 2 μg/min per kg (n=10, mean gestational and post-natal ages 32.1 weeks and 5.6 days, respectively) were also studied. In full-term infants, ET-1 concentration fell from 34.3±1.8 pmol/l on day 1 to 21.5±1.5 pmol/l on day 5 (P<0.01). In premature infants its absolute value and its post-natal fall were similar in the 1st week and no further change occurred in weeks 2–5; it stabilized at levels between 17.1±2.2 and 16.7±1.7 pmol/l. These concentrations tended to be lower than those of 25.5±1.3, 23.0±1.0 and 26.2±0.7 pmol/l measured in three groups of older children. During the 1st week, daily ET-1 excretion remained unchanged in term infants (3.1±1.0 vs. 3.7±1.5 pmol/m2 per day), but there was a significant increase from 6.5±1.0 to 12.4±0.7 pmol/m2 per day (P<0.01) in premature infants. During weeks 2–5, preterm infants excreted more ET-1 than older children (P<0.01). In response to perinatal ashphyxia/infection and dopamine therapy, urinary ET-1 excretion markedly rose and there was a significant positive correlation between urine flow rate and ET-1 excretion (P<0.001). We conclude that ET-1 concentration rather than excretion rate may have a role in mediating the changes in renal functions that occur soon after birth. The pathophysiological significance of the flow-dependent increase in urinary ET-1 excretion needs to be further studied.
Similar content being viewed by others
References
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415
Inoue A, Yanagisawa M, Kimura S Kasulya Y, Miyauchi Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863–2867
Saida K, Mitsui Y, Ishida N (1989) A novel peptide, vasoactive intestinal constrictor, of a new (endothelin) peptide family. J Biol Chem 264: 14613–14616
Calron R, Kloog Y, Bdolah A, Sokolovsky M (1989) Functional endothelin/sarafotoxin receptors in rat heart myocytes: structure-activity relationships and receptor subtypes. Biochem Biophys Res Commun 163: 936–943
Masuda Y, Miyazaki H, Kondoh M, Watanabe H, Yanagisawa M, Masaki T, Murakami K (1989) Two different forms of endothelin receptors in rat lung. FEBS Lett 257: 208–210
Kimura S, Kasuya Y, Sawamura T, Shinmi O, Sugita Y, Yanagisawa M, Goto K, Masaki T (1988) Structure-activity relationship of endothelin: importance of C-terminal moiety. Biochem Biophys Res Commun 156: 1182–1186
Masaki T, Yanagisawa M, Goto K, Kimura S (1990) Role of endothelin in mechanisms of local blood pressure control. J Hypertens 8 [Suppl 7]: S107-S112
Sakamoto H, Sasaki S, Hirata Y, Imai T, Ando K, Ida T, Sakurai T, Yanagisawa M, Masaki T, Marumo F (1990) Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 169: 462–468
Kohan DE (1991) Endothelin synthesis by rabbit renal tubule cells. Am J Physiol 261: F221-F226
Ando K, Hirata Y, Takei Y, Kawakami M, Marumo F (1991) Endothelin-1-like immunoreactivity in human urine. Nephron 57: 36–39
Grone H-J, Laue A, Fuchs E (1990) Localization and quantification of125-I=endothelin binding sites in human fetal and adult kidneys — relevance to renal ontogeny and pathophysiology. Klin Wochenschr 68: 758–767
Bhat R, John E, Chari G, Fornell L, Raju T, Vidyasagar D (1992) Endothelin-1 (ET-1) induced glomerular dysfunction: dose versus renal function (abstract). Pediatr Res 31: 329A
Harris PJ, Zhou J, Mendelsohn FAO, Skinner SL (1991) Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J Physiol 433: 25–39
Zeidel ML, Brady HR, Kone BC, Gullans SR, Brenner BM (1989) Endothelin is a peptide inhibitor of Na+-K+-ATP-ase in intact renal tubular epithelial cells. Am J Physiol 257: C1101-C1107
Fukuda Y, Hirata H, Yoshimi H, Kojima T, Kobayashi Y, Yanagisawa M, Masaki T (1988) Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem Biophys Res Commun 155: 167–172
Oishi R, Nonoguchi H, Tomita K, Marumo F (1991) Endothelin-1 inhibits AVP-stimulated osmotic water permeability in rat inner medullary collecting duct. Am J Physiol 261: F951-F956
Iwata I, Takagi T, Yamaji K, Tanizawa O (1991) Increase in the concentration of immunoreactive endothelin in human pregnancy. J Endocrinol 129: 301–307
Sanchez ME, Reale MR, Girardi LM, Dweck HS (1992) Endothelin (ET) in the urine of newborn infants (abstract). Pediatr Res 31: 342A
Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y (1988) Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249–252
Simson MS, Wann S, Mene P, Dubayak G, Kester M, Wakazato Y, Sedor JR, Dunn MJ (1989) Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83: 708–712
Takuwa N, Takuwa Y, Yanagisawa H, Kudo M, Yanagisawa M, Masaki T (1989) A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264: 7856–7861
Benigni A, Perico N, Gaspari F, Zoja C, Bellizi L, Gabanelli M, Remuzzi G (1991) Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 260: F331-F339
Ohta K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomitak K, Marumo F (1991) Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 39: 307–311
Rascher W, Manz F, Kleschin K, Feth F, Worgall S (1992) Endothelin excretion in children with renal diseases (abstract). Pediatr Nephrol (in press)
Simson MS, Dunn MJ (1991) Endothelin peptides: a possible role in glomerular inflammation. Lab Invest 64: 1–4
Schultz PJ (1992) An emerging role for endothelin in renal disease. J Lab Clin Med 119: 448–449
Felder RA, Felder CC, Eisner GN, Pedro AJ (1989) The dopamine receptor in adult and maturing kidney. Am J Physiol 257: F315-F327
Tulassay T, Seri I, Machay T, Kiszel I, Varga J, Csömör S (1983) Effects of dopamine on renal function in premature neonates with respiratory distress syndrome. Int J Pediatr Nephrol 4: 19–23
Yamauchi M, Kobayashi Y, Shimoura K, Hattori K, Nakase A (1992) Endothelin-dependent and-independent relaxation by dopamine in the rabbit pulmonary artery. Clin Exp Pharmacol Physiol 19: 401–410
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sulyok, E., Ertl, T., Adamovit, K. et al. Urinary endothelin excretion in the neonate: influence of maturity and perinatal pathology. Pediatr Nephrol 7, 881–885 (1993). https://doi.org/10.1007/BF01213378
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01213378